United Kingdom: Medicines and Healthcare Products Regulatory Agency [clinicaltrials_resource:556e9e8d4e19850cdd2b3e09a243711e]
clinicaltrials:NCT00061919clinicaltrials:NCT00275132clinicaltrials:NCT00309972clinicaltrials:NCT00532727clinicaltrials:NCT00554775Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics [clinicaltrials:NCT00655616]CS-8958 Single Inhaled Dose in Elderly [clinicaltrials:NCT00657111]clinicaltrials:NCT00700531Decapeptyl SR With Livial Add Back Therapy in the Management of Chronic Cyclical Pelvic Pain in Pre Menopausal Women [clinicaltrials:NCT00735852]clinicaltrials:NCT00824785Natural Versus HRT Cycles in Frozen Embryo Replacement Treatment [clinicaltrials:NCT00843570]clinicaltrials:NCT00845364clinicaltrials:NCT00942292clinicaltrials:NCT01006538clinicaltrials:NCT01095172A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People [clinicaltrials:NCT01123915]RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) Trial [clinicaltrials:NCT01127542]clinicaltrials:NCT01130376clinicaltrials:NCT01140737Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults [clinicaltrials:NCT01151319]A Trial of Rosuvastatin in Systemic Lupus Erythematosus [clinicaltrials:NCT01170585]Dose Escalation Study to Evaluate the Penetration and Pharmacodynamic Effects of Baminercept in the Cerebrospinal Fluid (CSF)and Safety in Subjects With Secondary Progressive Multiple Sclerosis (SPMS) [clinicaltrials:NCT01181089]Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy [clinicaltrials:NCT01225744]A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine [clinicaltrials:NCT01265914]Nitrites in Acute Myocardial Infarction [clinicaltrials:NCT01388504]Understanding Typhoid Disease After Vaccination [clinicaltrials:NCT01405521]clinicaltrials:NCT01415011AZithromycin Against pLacebo in Exacerbations of Asthma [clinicaltrials:NCT01444469]clinicaltrials:NCT01545323clinicaltrials:NCT01569919Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging [clinicaltrials:NCT01572025]Safety and Effectiveness of Intra-coronary Nitrite in Acute Myocardial Infarction [clinicaltrials:NCT01584453]clinicaltrials:NCT01601808clinicaltrials:NCT01610869clinicaltrials:NCT01617226Pasireotide Therapy in Patients With Nelson's Syndrome [clinicaltrials:NCT01617733]NUC-1031 in Patients With Advanced Solid Tumours [clinicaltrials:NCT01621854]MenPF-1 - A New Vaccine Against Meningococcal Disease [clinicaltrials:NCT01640652]Lymphatic Mapping for Sentinel Node Identification and Analysis [clinicaltrials:NCT01662752]clinicaltrials:NCT01662778
oversight [clinicaltrials_vocabulary:oversight]
United Kingdom: Medicines and Healthcare Products Regulatory Agency [clinicaltrials_resource:556e9e8d4e19850cdd2b3e09a243711e]
Bio2RDF identifier
556e9e8d4e19850cdd2b3e09a243711e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:556e9e8d4e19850cdd2b3e09a243711e
has dmc [clinicaltrials_vocabulary:has-dmc]
identifier
clinicaltrials_resource:556e9e8d4e19850cdd2b3e09a243711e
title
United Kingdom: Medicines and Healthcare Products Regulatory Agency
@en
type
label
United Kingdom: Medicines and ...... e9e8d4e19850cdd2b3e09a243711e]
@en